CureVac NV (NASDAQ:CVAC)
| 43.62 Delayed Data As of Dec 03 |  -0.33 / -0.75%Today’s Change | 35.05 Today|||52-Week Range 151.80 | -46.19% Year-to-Date |
Latest CVAC News | Press Releases
No recent news for CureVac NV.
Today’s Trading
| Previous close | 43.95 |
| Today’s open | 43.17 |
| Day’s range | 42.44 - 44.43 |
| Volume | 15,753 |
| Average volume (3 months) | 694,232 |
| Market cap | -- |
Data as of 3:59pm ET, 12/03/2021
Growth & Valuation
| Earnings growth (last year) | -86.20% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +41.47% |
| Revenue growth (last year) | +185.81% |
| P/E ratio | NM |
| Price/Sales | 192.37 |
| Price/Book | -- |
Competitors
| No competitors data available. |
Financials
| Next reporting date | April 14, 2022 |
| EPS forecast (this quarter) | -$0.64 |
| Annual revenue (last year) | $55.7M |
| Annual profit (last year) | -$147.2M |
| Net profit margin | -264.21% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
